Rate My Professor Rosemary Hollick

Dr Rosemary Hollick holds the position of Senior Clinical Lecturer in Rheumatology within the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen, and directs the Aberdeen Centre for Research Excellence in Musculoskeletal Health. Her academic background includes a BSc (Hons) in Biomedical Sciences (Pharmacology) from the University of Aberdeen in 1999, an MBChB (Hons) in Medicine from the University of Glasgow in 2004, a PhD (Doctorate of Medicine) from the University of Aberdeen in 2017, and fellowship of the Royal College of Physicians of Edinburgh (FRCP) in 2019. She completed her specialist training in rheumatology in 2017 and has served as an Honorary Consultant Rheumatologist with NHS Grampian since then, while taking on the role of National Clinical Lead for the Scottish Systemic Vasculitis Managed Clinical Network in 2023.

Dr Hollick's research interests centre on enhancing the design, delivery, and experience of health and care services for individuals with rheumatic and musculoskeletal diseases. She employs applied mixed-methods research, combining routine health data, qualitative methods, epidemiology, and patient partnerships to tackle issues in diagnosis, access, and long-term management, with particular emphasis on rare autoimmune rheumatic diseases, fibromyalgia, and rural health disparities. Over the past seven years, she has obtained more than £9 million in research funding. Her contributions have earned recognition through awards such as the NIHR Innovation and Inclusion Award in 2022 for patient partner involvement in the VOICES study and a place in Arthritis UK's Top 10 Research Highlights of 2024 for the same project. Selected key publications include 'A meta-analysis of smoking and fracture risk to update the FRAX® tool' (2026, Osteoporosis International), 'Patterns of Healthcare Use, Comorbidities, and Treatment of Fibromyalgia: Insights from Survey and Administrative Healthcare Data in Scotland and Wales' (2025, PACFiND), and 'Healthcare use in individuals with rheumatoid arthritis during the COVID-19 pandemic and beyond: A cohort study in three nations of the UK' (2025, Rheumatology). Additionally, she influences the field through roles including Associate Editor of Rheumatology (Oxford) since 2022, Deputy Chair of the British Society for Rheumatology Heberden Committee (2021-2025), steering committee member of the UK and Ireland Vasculitis Society, member of the Scotland Rare Disease Implementation Board since 2023, and member of the Scottish Parliament Cross Party Group on Arthritis and Musculoskeletal Conditions since 2020.